Pharmafile Logo

The (inevitable) digital transformation of Medical Affairs

It’s not a question of ‘if,’ it’s a question of ‘when.’

Working closely with Medical Affairs (MA) leaders and their teams, we have been hearing about their ongoing evolution and digital transformation for years. As in many other sectors, the pace of this transformation has accelerated substantially since the pandemic. Reviewing the recent literature on the topic, it is interesting to note how many predictions are already coming true but also where more work is needed to bring the visions to life.

A Vision for Medical Affairs

In A Vision for Medical Affairs in 2025–a recent McKinsey & Company report–the authors provided thought-provoking insights into the evolution of MA, mirroring what we have been hearing first-hand.

The report concluded that digital offers the ability to harness untapped insights through new or underused types of data and analytics, including real-world evidence, customer interaction, electronic health record, and internal data. It also highlighted that digital provides new ways for MA members to connect and engage with stakeholders. Healthcare providers (HCPs), payers, and patients can now access medical information at their fingertips and they expect more from Pharma than in the past. This offers new opportunities to engage with stakeholders beyond just physicians. However, MA must play a critical role in ensuring that digital information is factual, relevant, digestible, and tailored to the intended audience.

In addition to embracing the power of data and analytics, MA needs to get comfortable with novel digital engagement techniques. The pandemic accelerated the uptake of virtual meeting and event technologies. Nonetheless, many of these initiatives continue to occur on an ad hoc basis instead of ongoing engagement throughout the year, indicating that there is room for improvement… Read the rest of the article here.

This content was provided by Impetus Digital

Company Details

 Latest Content from  Impetus Digital 

Attacking COVID-19 from All Angles

Michael Taylor, CEO & Founder of Environmental Surface Solutions, explores alternative and supplementary approaches to fighting COVID-19 and other pathogens. In particular, we focus on environmental solutions for not only eradicating...

Importance of Patient Advocacy in Improving Healthcare

Eva Villalba, Executive Director of the Quebec Cancer Coalition, explores the importance of patient advocacy in improving healthcare. Among many other things, we dive into how the industry can help support...

Improving Patient Care by Removing Barriers to Drug Accessibility

Alan Birch, Founder & President of Drug Access Canada, discusses all things drug access and reimbursement. Among many other things, we explore the hurdles faced by patients and drug access navigators and...

Reimagining the Patient Journey

Kimberly Tableman, CEO at Medicine X, discusses a myriad of topics related to digital transformation and patient centricity, including how digital health technologies can be used to reimagine the patient...

Environmental impact of in-person vs. virtual meetings

Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...

Leadership Lessons Learned from the Pandemic

Alok Kanti, President & CEO of Bayer Canada, discusses a variety of topics, including his experience with leading an entire organization through the COVID-19 pandemic and where he sees digital health...

Overcoming Behavioral Health Access Limitations Through Telemedicine

Phil Hirsh, PhD, Founder & Chief Executive at Synergia Integrated teleBehavioral Health; and Craig Wright, MD, Senior Physician Executive and Consultant, discuss a range of topics surrounding telemedicine and other digital health...

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.

Pharma, Technology, and Healthcare in the New Normal

Brian Canestraro, General Manager at Intercept Pharmaceuticals, discusses a range of hot topics, from Brian’s leadership lessons and tips to the impact of the COVID-19 pandemic on the way that Pharma...